Galectin Therapeutics (GALT)
(Delayed Data from NSDQ)
$2.32 USD
+0.13 (5.94%)
Updated Aug 16, 2024 04:00 PM ET
After-Market: $2.31 -0.01 (-0.43%) 5:46 PM ET
3-Hold of 5 3
D Value D Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/11/2024
Time: -- |
9/2024 | $-0.17 | 0.00% |
Earnings Summary
For their last quarter, Galectin Therapeutics (GALT) reported earnings of -$0.20 per share, missing the Zacks Consensus Estimate of -$0.16 per share. This reflects a negative earnings surprise of 25.00%. Look out for GALT's next earnings release expected on November 11, 2024. For the next earning release, we expect the company to report earnings of -$0.17 per share, reflecting a year-over-year increase of 29.17%.
Earnings History
Price & Consensus
Zacks News for GALT
What Makes Galectin Therapeutics Inc. (GALT) a New Buy Stock
GALT: What are Zacks experts saying now?
Zacks Private Portfolio Services